Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine

Mahidol University172 enrolled

Overview

The purpose of this study is to determine the outcomes of treating epidemic keratoconjunctivitis with 2% povidone-iodine.

The study design was a prospective interventional case series. Our institutional ethical committee approved the study protocol in April 2004. We performed this study between July 2004 and December 2009. During this period, there were 2 episodes of EKC epidemic. The first episode was in 2006 and the second in 2009.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

172

Conditions

Viral Conjunctivitis

Interventions

2% povidone-iodineDRUG

apply 4 times a day for one week

2% povidone-iodineDRUG

apply 2% povidone-iodine 4 times per day for one week

Eligibility

Sex: ALLMin age: 7 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients who were diagnosed with EKC at the outpatient ophthalmic unit Exclusion Criteria: * children younger than six years * women being pregnant or during lactation * history of allergy to povidone-iodine * prior ocular surgery * contact lens usage and chronic eye diseases with current eye medications.

Locations (1)

Department of Ophthalmology, Siriraj Hospital Mahidol University

Bangkoknoi, Bangkok, Thailand

Outcomes

Primary Outcomes

the recovery rate within one week of treatment

Time frame: 1 week

Secondary Outcomes

drug tolerability

proportion of patient who can continue topical application of povidone-iodine for a week or until EKC subsides

Time frame: 1 week

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.